Literature DB >> 15129977

Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications.

D Gopinath1, D Ravi, B R Rao, S S Apte, D Renuka, D Rambhau.   

Abstract

Vesicles with biological activity or with a targeting function in addition to carrier properties will have an added advantage. Vesicles prepared with amphiphiles having antioxidant property may have potential applications towards disorders implicated with reactive oxygen species. Ascorbyl palmitate (ASP) was explored as bilayer vesicle forming material. It formed vesicles (Aspasomes) in combination with cholesterol and a negatively charged lipid (dicetyl phosphate). Aspasomes were prepared by film hydration method followed by sonication in which aqueous azidothymidine (AZT) solution was encapsulated in aqueous regions of bilayer. Aspasomes were obtained with all compositions containing 18-72 mol% cholesterol. Differential scanning calorimetric data of aspasome dispersion and anhydrous mixtures of ascorbyl palmitate, cholesterol and dicetyl phosphate confirm the formation of bilayered vesicles with ascorbyl palmitate. Cholesterol content in aspasome did not exhibit any relation with vesicle size, zeta potential or percent entrapment. A substantial change in release rate of azidothymidine from aspasome was noticed on varying the proportion of cholesterol. Release rate and cholesterol content in Aspasomes did not exhibit any relation. A preparation with 45 mol% of cholesterol showed maximum retardation in release rate, than other compositions. The change in capture volume with time (latency) was studied for 8 h and with such a short duration study it was difficult to predict long term stability of these vesicles. But release experiments do indicate stability up to 18 h. Percent reducing activity of aspasome was estimated by measuring the absorbance of alpha,alpha-diphenyl-beta-picrylhydrazyl (DPPH) at 517 nm after addition of test antioxidant samples. These studies revealed that the antioxidant potency of ascorbyl moiety is retained even after converting ascorbyl palmitate into vesicles (Aspasomes). The antioxidant potency of Aspasomes was assessed by measuring the protection offered by this preparation against quinolinic acid induced lipoperoxidation of whole human blood in vitro, where in the lipoperoxidation was monitored by measuring thiobarbituric acid reactive substances (TBARS) levels. Aspasome rendered much better antioxidant activity than ascorbic acid. Transdermal permeation of aspasomal AZT, ASP-AZT aqueous dispersion and AZT-solution across excised rat skin was investigated in vitro using Franz diffusion cell. Permeation of aspasomal AZT was much higher than the other two preparations. However, ASP-AZT aqueous dispersion has also enhanced permeation of AZT significantly over the AZT-solution, indicating skin permeation enhancing property of ascorbyl palmitate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15129977     DOI: 10.1016/j.ijpharm.2003.10.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

1.  Palmitoyl ascorbate-loaded polymeric micelles: cancer cell targeting and cytotoxicity.

Authors:  Rupa R Sawant; Onkar Vaze; Gerard G M D'Souza; Karen Rockwell; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2010-08-21       Impact factor: 4.200

2.  A Nanocarrier Skin-Targeted Drug Delivery System using an Ascorbic Acid Derivative.

Authors:  Yutaka Inoue; Mitsue Hibino; Isamu Murata; Ikuo Kanamoto
Journal:  Pharm Res       Date:  2017-12-28       Impact factor: 4.200

3.  Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy.

Authors:  Junxiu Li; Chaorui Guo; Fan Feng; Ali Fan; Yu Dai; Ning Li; Di Zhao; Xijing Chen; Yang Lu
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

4.  Formulation and optimization of Zidovudine niosomes.

Authors:  Kandasamy Ruckmani; Veintramuthu Sankar
Journal:  AAPS PharmSciTech       Date:  2010-07-16       Impact factor: 3.246

5.  Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles.

Authors:  Maja Ledinski; Ivan Marić; Petra Peharec Štefanić; Iva Ladan; Katarina Caput Mihalić; Tanja Jurkin; Marijan Gotić; Inga Urlić
Journal:  Polymers (Basel)       Date:  2022-04-26       Impact factor: 4.967

6.  Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro.

Authors:  Gerard G M D'Souza; Tao Wang; Karen Rockwell; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2008-07-11       Impact factor: 4.200

7.  Drug nanoparticle formulation using ascorbic Acid derivatives.

Authors:  Kunikazu Moribe; Waree Limwikrant; Kenjirou Higashi; Keiji Yamamoto
Journal:  J Drug Deliv       Date:  2011-04-26

8.  Ascorbic Acid for the safe use of a sunscreen agent: accumulation of nano zinc oxide and titanium dioxide on the skin.

Authors:  Anahita Fathi-Azarbayjani; Poh Leng Tan; Yew Ying Chan; Sui Yung Chan
Journal:  Sci Pharm       Date:  2013-07-14

9.  Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo.

Authors:  Youwen Zhang; Deyin Tong; Daobiao Che; Bing Pei; Xiaodong Xia; Gaofeng Yuan; Xin Jin
Journal:  Int J Nanomedicine       Date:  2017-01-16

10.  Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.

Authors:  Dinesh Kumar; Deepak Sharma; Gurmeet Singh; Mankaran Singh; Mahendra Singh Rathore
Journal:  ISRN Pharm       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.